izpis_h1_title_alt

N-hydroxy-N-propargylamide derivatives of ferulic acid : inhibitors of cholinesterases and monoamine oxidases
ID Bautista-Aguilera, Oscar M. (Avtor), ID Alonso, José M. (Avtor), ID Catto, Marco (Avtor), ID Iriepa, Isabel (Avtor), ID Knez, Damijan (Avtor), ID Gobec, Stanislav (Avtor), ID Marco-Contelles, José (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (792,16 KB)
MD5: 43DB8F68B71C521F26574F9486E9F3A9
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1420-3049/27/21/7437 Povezava se odpre v novem oknu

Izvleček
Alzheimer’s disease (AD) is a complex disorder characterized by impaired neurotransmission in cholinergic and monoaminergic neurons, which, in combination with the accumulation of misfolded proteins and increased oxidative stress, leads to the typical features of the disease at the biomolecular level. Given the limited therapeutic success of approved drugs, it is imperative to explore rationally supported therapeutic approaches to combat this disease. The search for novel scaffolds that bind to different receptors and inhibit AD disease-related enzymes could lead to new therapeutic solutions. Here, we describe N-hydroxy-N-propargylamide hybrids 1–6, which were designed by combining the structures of Contilisant—a multifunctional anti-AD ligand—and ferulic acid, a natural antioxidant with various other biological activities. Among the synthesized compounds, we identified compound 4 as a micromolar inhibitor of hAChE with a potent radical-scavenging capacity comparable to resveratrol and Trolox. In addition, compound 4 chelated copper(II) ions associated with amyloid β pathology, mitochondrial dysfunction, and oxidative stress. The promising in vitro activity combined with favorable drug-like properties and predicted blood‒brain barrier permeability make compound 4 a multifunctional ligand that merits further studies at the biochemical and cellular levels.

Jezik:Angleški jezik
Ključne besede:cholinesterases, ferulic acid, molecular modelling, monoamine oxidase, radical-scavenger, antioxidant
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2022
Št. strani:18 str.
Številčenje:Vol. 27, iss. 21, art. 7437
PID:20.500.12556/RUL-142354 Povezava se odpre v novem oknu
UDK:616.894
ISSN pri članku:1420-3049
DOI:10.3390/molecules27217437 Povezava se odpre v novem oknu
COBISS.SI-ID:127684867 Povezava se odpre v novem oknu
Datum objave v RUL:02.11.2022
Število ogledov:573
Število prenosov:95
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Molecules
Skrajšan naslov:Molecules
Založnik:MDPI
ISSN:1420-3049
COBISS.SI-ID:18462981 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:holinesteraze, ferulna kislina, molekularno modeliranje, monoaminooksidaza, lovilec radikalov, antioksidant

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0208-2015
Naslov:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj